FDA clears Ziehm mobile C-arm
No sooner had RadNet completed its two-month-old deal to acquire nine New Jersey imaging centers than the company began whittling down the purchase price, turning new assets into hard cash. RadNet sold off a single-modality open MRI center in southern New Jersey, along with some legacy image management systems, for $650,000, thus retrieving a chunk of the $2.1 million paid to Medical Resources for the nine facilities. Tristate Imaging bought the center, which RadNet described as being outside the market served by the closest RadNet centers. The acquisition price will drop further if RadNet sells, as planned, a building in Union, NJ, that it acquired in the deal. The Medical Resources acquisition is part of a strategy to connect RadNet's Mid-Atlantic and southern New York operations. These complement core operations in California, Maryland, and Delaware. All told, RadNet operates a network of 175 fully owned and operated outpatient imaging centers.
The FDA has cleared the Vision RFD, a mobile C-arm from Ziehm Imaging. The compact system is designed for use in endovascular surgery, interventional cardiology, and interventional radiology. It features a flat-panel sensor as part of its digital imaging chain. A large C-arm opening and 165º orbital rotation allow easy patient access.
What a New Meta-Analysis Reveals About PET/CT Radiotracers for csPCa
February 6th 2025The PET/CT agent 18F-PSMA-1007 offered the highest surface under the cumulative ranking curve (SUCRA) out of nine radiotracers at the patient and lesion level for detecting clinically significant prostate cancer (csPCa), according to a meta-analysis.
New CT Angiography Study Shows Impact of COVID-19 on Coronary Inflammation and Plaque
February 5th 2025Prior COVID-19 infection was associated with a 28 percent higher progression of total percent atheroma volume (PAV) annually and over a 5 percent higher incidence of high-risk plaque in patients with coronary artery lesions, according to CCTA findings from a new study.